4//SEC Filing
Lorrain Daniel S. 4
Accession 0001437749-25-002431
CIK 0001855175other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:38 PM ET
Size
7.8 KB
Accession
0001437749-25-002431
Insider Transaction Report
Form 4
Lorrain Daniel S.
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-31+3,700→ 3,700 total(indirect: By Spouse)Exercise: $9.79Exp: 2035-01-30→ Class A Common Stock (3,700 underlying) - Award
Stock Option (right to buy)
2025-01-31+110,000→ 110,000 totalExercise: $9.79Exp: 2035-01-30→ Class A Common Stock (110,000 underlying)
Footnotes (2)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"). 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.
- [F2]Options granted under the Plan in connection with Reporting Person's spouse's continuous service at the Company. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's spouse's continuous service.
Documents
Issuer
Contineum Therapeutics, Inc.
CIK 0001855175
Entity typeother
Related Parties
1- filerCIK 0001861550
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:38 PM ET
- Size
- 7.8 KB